Key Takeaways:
- A class action lawsuit has been filed against PACS Group, Inc., alleging securities fraud.
- Investors who bought stock during the April 2024 IPO or between April 11 and November 5, 2024, are affected.
- Allegations include submitting false Medicare claims and billing unnecessary therapies.
- The deadline to request appointment as lead plaintiff is January 13, 2025.
- Levi & Korsinsky, LLP has a strong track record in securities litigation.
Investors Urged to Act Before Deadline
As the January 13, 2025 deadline nears, Levi & Korsinsky, LLP has notified investors of a class action securities lawsuit filed against PACS Group, Inc. (NYSE: PACS). The lawsuit seeks to recover losses on behalf of investors who were adversely affected by alleged securities fraud committed by the company.
Allegations of Fraudulent Schemes
The lawsuit alleges that PACS Group engaged in schemes to submit false Medicare claims, which “drove more than 100% of PACS’ operating and net income from 2020 – 2023.” Additionally, the company is accused of billing “thousands of unnecessary respiratory and sensory integration therapies to Medicare” and falsifying documentation related to licensure and staffing.
Impact on Shareholders
Investors who purchased or otherwise acquired PACS Group common stock pursuant to the registration statement and prospectus issued in connection with the company’s April 11, 2024 initial public offering—and those who bought securities between April 11, 2024, and November 5, 2024—are impacted by these allegations. The purported schemes may have misled investors about the company’s true financial health.
Legal Action and Investor Options
Affected investors have until January 13, 2025, to request that the court appoint them as lead plaintiff—a role that allows investors to act on behalf of other class members in directing the litigation. However, participation in any potential recovery does not require serving as lead plaintiff.
No Cost to Participate
Investors who are class members may be entitled to compensation without any out-of-pocket costs or fees. Levi & Korsinsky emphasizes that there is no cost or obligation to participate in the lawsuit.
Levi & Korsinsky’s Proven Track Record
With over 20 years of experience, Levi & Korsinsky, LLP has secured hundreds of millions of dollars for aggrieved shareholders. The firm specializes in complex securities litigation and boasts a team of over 70 employees dedicated to serving their clients. For seven consecutive years, they have ranked in ISS Securities Class Action Services’ Top 50 Report among the top securities litigation firms in the United States.
Next Steps for Affected Investors
Investors interested in participating or seeking more information are encouraged to contact Levi & Korsinsky, LLP. Joseph E. Levi, Esq. is available via email at
or by telephone at (212) 363-7500.Conclusion
The serious allegations against PACS Group, Inc. highlight the importance of corporate transparency and accountability. Affected investors are urged to consider their legal options and act promptly before the upcoming deadline.
